BILL ANALYSIS
SB 472
Page 1
Date of Hearing: July 3, 2007
ASSEMBLY COMMITTEE ON BUSINESS AND PROFESSIONS
Mike Eng, Chair
SB 472 (Corbett) - As Amended: June 20, 2007
SENATE VOTE : 27-10
SUBJECT : Prescription drugs: labeling requirements.
SUMMARY : Requires the Board of Pharmacy to promulgate
regulations that require a standardized, patient-centered,
prescription drug label on all prescription medication dispensed
to patients in California. Specifically, this bill :
1)Requires the Board of Pharmacy to do all of the following:
a) Promulgate regulations that require, on or before
January 1, 2011, a standardized, patient-centered,
prescription drug label on all prescription medicine
dispensed to patients in California;
b) Hold public meetings statewide, that are separate from
its normally scheduled hearings, in order to seek
information from groups representing consumers, seniors,
pharmacists or the practice of pharmacy, other health care
professionals, and other interested parties;
c) Consider all of the following factors when developing
the requirements for prescription drug labels:
i) Medical literacy research that points to increased
understandability of labels;
ii) Improved directions for use;
iii) Improved font types and sizes;
iv) Placement of information that is patient-centered;
v) The needs of those patients with limited English
proficiency;
vi) The needs of seniors; and,
vii) Technology requirements necessary to implement the
standards;
d) Report to the Legislature by January 1, 2010, on its
progress under this bill; and,
e) Report to the Legislature by January 1, 2013, the status
SB 472
Page 2
of implementation of the prescription drug label
requirements adopted pursuant to this bill.
2)Makes various findings related to the cost and use of
prescription drugs and the need to reduce medication-related
errors.
EXISTING LAW :
1)Establishes the Pharmacy Law, which provides for the
licensing, regulation and enforcement of the practice of
pharmacy by the Board of Pharmacy. Makes it a misdemeanor to
violate the Pharmacy Law.
2)Requires dispensed prescription drugs to be correctly labeled
with all of the following:
a) The trade name of the drug or the generic name and the
name of the manufacturer;
b) The directions for the use of the drug;
c) The name of the patient;
d) The name of the prescriber;
e) The date of issue;
f) The name and address of the pharmacy, and the
prescription number;
g) The strength of the drug;
h) The quantity of the drug or drugs dispensed;
i) The expiration date of the effectiveness of the drug;
j) The condition for which the drug was prescribed if
requested by the patient and if the condition is indicated
on the prescription; and,
aa) The physical description of the drug, including its
color, shape, and any identification code that appears on
the tablets or capsules, except as specified.
FISCAL EFFECT : Unknown
COMMENTS :
Purpose of this bill . According to the author's office, this
bill is necessary to make prescription drug labels easy to
understand. The author cites a number of reports as evidence of
the need for this bill. According to the Institute of Medicine,
medication errors are among the most common medical errors,
harming at least 1.5 million people annually. An article in the
Journal of the American Medical Association states that 46% of
SB 472
Page 3
adults cannot understand the information on the label of their
pill bottles. A 2006 Annals of Internal Medicine study found
that although 70.7% of patients with low literacy could
correctly repeat dosing instructions, only 34.7% could
demonstrate the correct number of pills to be taken daily.
Families USA reports that 40% of medications are taken
incorrectly by Medicare patients. According to the 2005 U.S.
Census, more than one in five Californians speak English "less
than very well." Separate studies show that limited English
proficient patients have a harder time understanding the
information on their prescription drug labels and have lower
levels of adhering to their medication regimens. For all these
reasons, the author believes that standardized prescription drug
labels would facilitate patient understanding of the information
contained on these labels.
Background . In March 2007, the Medication Errors Panel (Panel),
established pursuant to SCR 49 (Speier), Resolution Chapter 123,
Statutes 2005, published its report, Prescription for Improving
Patient Safety: Addressing Medication Errors. The report listed
six general goals to reduce medication errors. Under each goal
were recommendations (twelve in all) and methods to accomplish
each recommendation. The goal relevant to the subject matter of
this bill is: "Improve prescriber-pharmacist and
pharmacist-consumer communications to enhance understanding of
the intended use of prescribed medication." To accomplish this
goal, the panel recommended the California Board of Pharmacy and
Medical Board of California pursue statutory and regulatory
changes that would require that the intended use of the
medication be included on all prescriptions and require that the
intended use of medication be included on medication
label/labeling unless disapproved by the prescriber or the
patient.
The Panel report also stated that "the information that
consumers need to know about their medication is often complex
and may include unfamiliar language or concepts. Expecting a
consumer to retain all the pertinent knowledge from a brief
verbal encounter may not be reasonable in many instances." The
report cited the importance of consumers having written
information regarding their prescription. However, the report
also stated that this information can be forgotten and lost, and
in those instances, consumers may be left with nothing more than
the prescription packaging and label to guide them. Testimony
provided to the Panel identified many limitations related to the
SB 472
Page 4
prescription label as an effective communication tool. These
included the limited size of a prescription label (approximately
2 x 3 inches) which, due to established pharmacy systems,
processes, and drug container variability, would be functionally
and financially difficult for the pharmacy industry to change.
Further complicating matters is the fact that there is already a
significant amount of information required by California law to
be printed on the label. The most recent label requirement went
into effect on January 1, 2006, and was created to help
consumers identify erroneously filled prescriptions by mandating
that pharmacies include the physical description of the
dispensed medication, including its color, shape, and any
identification code that appears on the tablets or capsules.
This bill will require a comprehensive review of prescription
label requirements and implementation of changes that will
provide consumers with elements of the most valuable pieces of
information
Support . Proponents state that prescription medications are an
essential part of health care and contribute to increasing both
quality and life expectancy of patients, but despite their
importance, many Californians face challenges understanding and
complying with their medication regimen. All too often, medical
errors have dire consequences. In fact, proponents argue,
medication errors are a leading cause for hospitalizations in
the United States. Proponents further suggest that national
trends are moving toward improving the readability of
prescription labels. They state that Target Pharmacy has
created the ClearRX system to reduce medication errors, and
Walgreen's Pharmacy produces labels in more than 10 languages,
indicating that standardization and translation are realistic
goals for California.
Opposition . The California Alliance for Consumer Protection
opposes this bill because it believes the Rx Cannabis industry
does not feel labels should be required on cannabis
prescriptions, but this bill's labeling requirements should
apply to sample prescription drugs.
Related legislation . AB 1276 (Karnette) of 2007, which would
have required prescribers of medications to ask patients whether
or not to indicate the intended purpose of the prescription on
the prescription's label, failed passage in the Assembly
Business and Professions Committee.
SB 472
Page 5
REGISTERED SUPPORT / OPPOSITION :
Support
Latino Coalition for a Healthy California (sponsor)
Gray Panthers California (sponsor)
Senior Action Network (sponsor)
California State Board of Pharmacy
AIDS Healthcare Foundation
American Federation of State, County and Municipal Employees
Applied Research Center
Asian Pacific American Legal Center of Southern California
California Alliance for Retired Americans
California Association of Public Authorities for In- Supportive
Services
California Medical Association
Latino Health Alliance
Mexican American Legal Defense and Education Fund
Pharmacist's Planning Service, Inc.
Southern California HIV Advocacy Coalition
Opposition
The California Alliance for Consumer Protection
Analysis Prepared by : Ross Warren / B. & P. / (916) 319-3301